Equity Clock

Arithmetic Average Seasonal Chart

Geometric Average Seasonal Chart

HSKA Relative to the S&P 500

HSKA Relative to the Sector

% of Revenue Generated in Each Quarter

% of Free Cash Flow Generated in Each Quarter

% of Net Income Generated in Each Quarter

Seasonal Chart Analysis

Analysis of the Heska Corp. (NASD:HSKA) seasonal charts above shows that a Buy Date of December 13 and a Sell Date of March 13 has resulted in a geometric average return of 17.59% above the benchmark rate of the S&P 500 Total Return Index over the past 20 years. This seasonal timeframe has shown positive results compared to the benchmark in 16 of those periods. This is a very good rate of success and the return strongly outperforms the relative buy-and-hold performance of the stock over the past 20 years by an average of 12.7% per year.

The seasonal timeframe correlates Poorly with the period of seasonal strength for the Healthcare sector, which runs from April 25 to December 4. The seasonal chart for the broad sector is available via the following link: Healthcare Sector Seasonal Chart.

Heska Corp is engaged in developing, manufacturing, marketing, selling & supporting veterinary products. The company’s segments are Core Companion Animal Health & Other Vaccines, Pharmaceuticals and Products. The CCA segment includes, primarily for canine & feline use, a point of care laboratory instruments & supplies, digital imaging products, software & services, local & cloud-based data services, allergy testing & immunotherapy, & single-use offerings such as point of care diagnostic tests and heartworm preventive products. The OVP segment includes private label vaccine and pharmaceutical production, primarily for cattle but also for other species including equine, porcine, avian, feline & canine.

To download HSKA seasonal chart data, please log in or Subscribe.

Stocks mentioned in this post: HSKA